Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin

1130 patients with stable coronary artery disease (respondents from a representative sample of 1222 patients participating in the LIPID study)

Pravastatin sodium 40 mg/d for at least 4 years

Placebo for at least 4 years

Psychological well-being (anxiety and depression, anger, impulsiveness, alcohol consumption, and adverse life events) assessed via standard self-administered questionnaire at baseline, 6 months, 1 year, 2 years, and 4 yearspatient reported